1. Tabakhiyan, F., A. Mir and V. Vahedian, 2022. Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6). Hormone Mol. Biol. Clin. Invest., 10.1515/hmbci-2022-0028.
   CrossRef  |  Direct Link  |  
2. Pourmohammad, P., N.F. Maroufi, M. Rashidi, V. Vahedian and F. Pouremamali et al., 2022. Potential therapeutic effects of melatonin mediate via miRNAs in cancer. Biochem. Genet., 60: 1-23.
   CrossRef  |  Direct Link  |  
3. Pouremamali, F., V. Vahedian, N. Hassani, S. Mirzaei and A. Pouremamali et al., 2022. The role of SOX family in cancer stem cell maintenance: With a focus on SOX2. Pathol. Res. Pract., Vol. 231. 10.1016/j.prp.2022.153783.
   CrossRef  |  Direct Link  |  
4. Maroufi, N.F., M. Rashidi, V. Vahedian, R. Jahanbazi and S. Mostafaei et al., 2022. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line. Breast Cancer, 29: 260-273.
   CrossRef  |  Direct Link  |  
5. Faridvand, Y., H. Kazemzadeh, V. Vahedian, P. Mirzajanzadeh and H.R. Nejabati et al., 2022. Dapagliflozin attenuates high glucose‐induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation. Clin. Exp. Pharm. Physiol., 49: 643-651.
   CrossRef  |  Direct Link  |  
6. Chavoshi, H., N. Poormolaie, V. Vahedian, H. Kazemzadeh and A. Mir et al., 2022. Vascular mimicry: A potential therapeutic target in breast cancer. Pathol. Res. Pract., Vol. 234. 10.1016/j.prp.2022.153922.
   CrossRef  |  Direct Link  |  
7. Bastani, S., V. Vahedian, M. Rashidi, A. Mir and S. Mirzaei et al., 2022. An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin. Biomed. Pharmacother., Vol. 153. 10.1016/j.biopha.2022.113297.
   CrossRef  |  Direct Link  |  
8. Maroufi, N.F., P. Pezeshgi, Z. Mortezania, P. Pourmohammad and R. Eftekhari, 2020. Association between vitamin D deficiency and prevalence of metabolic syndrome in female population: A systematic review. Hormone Mol. Biol. Clin. Invest., Vol. 41. 10.1515/hmbci-2020-0033.
   CrossRef  |  Direct Link  |  
9. Maroufi, N.F., N. Ashouri, Z. Mortezania, Z. Ashoori and V. Vahedian et al., 2020. The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor. Pathol. Res. Pract., Vol. 216. 10.1016/j.prp.2020.153226.
   CrossRef  |  Direct Link  |  
10. Maroufi, N.F., M. Amiri, B.F. Dizaji, V. Vahedian and M. Akbarzadeh et al., 2020. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. Eur. J. Pharmacol., Vol. 881. 10.1016/j.ejphar.2020.173282.
    CrossRef  |  Direct Link  |